Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Autoimmune Disorders

  Free Subscription


09.11.2026

2 Am J Kidney Dis
3 BMC Neurol
1 Brain
2 Diabetes Res Clin Pract
3 Intern Med
1 J Autoimmun
1 J Immunol
1 J Neurol
2 J Pediatr Endocrinol Metab
2 Kidney Int
4 Mult Scler
4 Neurology
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Kidney Dis

  1. BU L, Vaughan LE, Said SM, Zhu Y, et al
    Proliferative Glomerulonephritis With Monotypic Immunoglobulin Deposits of IgG1 Subclass: A Case Series.
    Am J Kidney Dis. 2026 Nov 2:S0272-6386(26)01196.
    PubMed         Abstract available

  2. BOWERS W, Garcia E, Wood N, Cater K, et al
    A Case of Bio-Dissimilarity: Rapidly Progressive Glomerulonephritis Following Switch From Infliximab to Infliximab-abda.
    Am J Kidney Dis. 2026 Oct 31:S0272-6386(26)01194.
    PubMed         Abstract available


    BMC Neurol

  3. VOTH J, Gerstmeyer J, Meuth SG, Zu Horste GM, et al
    Real-world hospitalization and readmission trajectory after Guillain-Barre syndrome in the United States.
    BMC Neurol. 2026;26:702.
    PubMed         Abstract available

  4. SUSLOW A, Lauer R, Gruter T, Hellwig K, et al
    Attitudes towards vaccination in multiple sclerosis: insights from patients, neurologists, and general practitioners within a qualitative study.
    BMC Neurol. 2026;26:697.
    PubMed         Abstract available

  5. SHUAIBU II
    Mitochondrial Haplogroup U and multiple sclerosis risk in Arab and Near Eastern populations: a systematic review and meta-analysis.
    BMC Neurol. 2026;26:685.
    PubMed         Abstract available


    Brain

  6. MORRISON AH, Yao T, Isfort MC, Morena J, et al
    Dysregulated CSF T-cell responses and their evolution after intravenous immunoglobulin in Guillain-Barre syndrome.
    Brain. 2026 Nov 5:awag379. doi: 10.1093.
    PubMed         Abstract available


    Diabetes Res Clin Pract

  7. YING H, Shen T, Yu HW, Ran L, et al
    Multiple islet autoantibodies are associated with C-peptide below the reporting limit and a limited fasting-to-120-minute increase in routine clinical testing.
    Diabetes Res Clin Pract. 2026 Nov 5:113631. doi: 10.1016/j.diabres.2026.113631.
    PubMed         Abstract available

  8. ZHENG T, Yang R, Li S, Wu X, et al
    Association between diabetes-related autoantibody positivity and renal impairment in clinically diagnosed type 2 diabetes: a cross-sectional study.
    Diabetes Res Clin Pract. 2026 Nov 3:113644. doi: 10.1016/j.diabres.2026.113644.
    PubMed         Abstract available


    Intern Med

  9. TANAKA K, Kawamura A, Suzuki R, Nagasaki T, et al
    VEXAS Syndrome with an Improvement of Chest Shadows without Immunosuppressive Therapy.
    Intern Med. 2026;65:2923-2928.
    PubMed         Abstract available

  10. YOSHIKAWA M, Goto Y, Tsutsumi M, Hirahara R, et al
    Real-world Application of Subcutaneous Efgartigimod in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Intern Med. 2026;65:2912-2917.
    PubMed         Abstract available

  11. SAKAI M, Matsuoka S, Takigawa Y, Kinoshita A, et al
    Early Benralizumab Use for the Successful Treatment of Eosinophilic Granulomatosis with Polyangiitis-associated Peripheral Neuropathy.
    Intern Med. 2026;65:2929-2933.
    PubMed         Abstract available


    J Autoimmun

  12. DAI Z, Zhang W, Wang C, Fan SH, et al
    Syphilis infection and autoimmune disease: A matched case-control study with clinical follow-up in 1,042 patients.
    J Autoimmun. 2026;165:103652.
    PubMed         Abstract available


    J Immunol

  13. VOLFSON-SEDLETSKY V, DeBerg HA, Fahning ML, Rifkin IR, et al
    The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity.
    J Immunol. 2026;215:vkag288.
    PubMed         Abstract available


    J Neurol

  14. VAN WIJMEERSCH B, Oreja-Guevara C, Magyari M, Airas L, et al
    Uncovering disability progression in people with multiple sclerosis: a practical guide.
    J Neurol. 2026;273:699.
    PubMed         Abstract available


    J Pediatr Endocrinol Metab

  15. SPEIDEL AJ, Krielen M, Brandt-Heunemann S, Wabitsch M, et al
    Diabetic cataract at type 1 diabetes onset: frequency and characteristics.
    J Pediatr Endocrinol Metab. 2026;39:1111-1117.
    PubMed         Abstract available

  16. STOLFI L, Scavone M, Placella E, Pesce S, et al
    Biphasic neonatal Graves disease following maternal thyroidectomy: a case report.
    J Pediatr Endocrinol Metab. 2026 Nov 9. doi: 10.1515/jpem-2026-0581.
    PubMed         Abstract available


    Kidney Int

  17. GERALD P, Claudius S, Daniela K, Anita S, et al
    Modified immune cell therapy targets kidney-resident tertiary lymphoid structures and ameliorates murine lupus nephritis.
    Kidney Int. 2026 Nov 5:S0085-2538(26)00910-5. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available

  18. CHANG DY, Sun Z, Li X, Cai W, et al
    Ontogenically distinct macrophages occupy discrete kidney niches and contribute to monocyte recruitment in experimental crescentic glomerulonephritis.
    Kidney Int. 2026 Nov 5:S0085-2538(26)00907-5. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available


    Mult Scler

  19. WRIGHT SL
    Pelvic neurology meets multiple sclerosis.
    Mult Scler. 2026 Nov 4:13524585261501838. doi: 10.1177/13524585261501838.
    PubMed        

  20. SHIRANI A, Stopschinski BE, Herz J, Calvier L, et al
    Lower recorded prevalence of Alzheimer's disease in natalizumab-exposed older adults with multiple sclerosis: A hypothesis-generating observation.
    Mult Scler. 2026 Nov 3:13524585261499995. doi: 10.1177/13524585261499995.
    PubMed         Abstract available

  21. KRIEGER SC, Bodhinathan K, Xu Y, Miskin HP, et al
    Multiple sclerosis relapse redefined: Effect of an MRI-supported relapse criterion on ublituximab outcomes in the ULTIMATE I and II trials.
    Mult Scler. 2026 Nov 3:13524585261499629. doi: 10.1177/13524585261499629.
    PubMed         Abstract available

  22. GELISSEN LMY, van den Berg SPH, Dorlo TPC, Wolbink G, et al
    Emergence of natalizumab anti-drug antibodies during extended interval dosing in a patient with multiple sclerosis: A case report.
    Mult Scler. 2026 Nov 2:13524585261500350. doi: 10.1177/13524585261500350.
    PubMed         Abstract available


    Neurology

  23. DI FILIPPO M, Masillo V, Di Sabatino E, Cordioli C, et al
    Impact of 2024 Revisions of Multiple Sclerosis Diagnostic Criteria in People With Radiologically Isolated Syndrome.
    Neurology. 2026;107:e218691.
    PubMed         Abstract available

  24. HEDSTROM AK, Olsson T, Alfredsson L
    Occupational Exposure to Petroleum-Derived Lubricants and Risk of Multiple Sclerosis.
    Neurology. 2026;107:e218718.
    PubMed         Abstract available

  25. FRASE S, Wiendl H
    Toward a Biology-Driven Diagnosis of Multiple Sclerosis: What the 2024 McDonald Criteria Mean for Radiologically Isolated Syndrome.
    Neurology. 2026;107:e218758.
    PubMed        

  26. MARRIE RA
    Timing Is Everything: Occupational Petrolatum-Based Lubricant Exposure and Multiple Sclerosis.
    Neurology. 2026;107:e218747.
    PubMed        


    Proc Natl Acad Sci U S A

  27. SUN Y, Liu L, Jiang M, Wan L, et al
    USP46 restrains K63-linked polyubiquitination-dependent aggregation and activation of the NLRP3 inflammasome in lupus nephritis.
    Proc Natl Acad Sci U S A. 2026;123:e2601940123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum